Literature DB >> 25189975

Cutaneous Rosai-Dorfman disease accompanied by Langerhans cell hyperplasia responsive to combined treatment.

Jin Wei1, Yu Zhang2, Jiang Jin1, Jianzhong Zhang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25189975

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  3 in total

1.  BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor.

Authors:  Rosemarie Mastropolo; Allison Close; Steven W Allen; Kenneth L McClain; Scott Maurer; Jennifer Picarsic
Journal:  Blood Adv       Date:  2019-06-25

2.  Bone pathologic fracture revealing an unusual association: coexistence of Langerhans cell histiocytosis with Rosai-Dorfman disease.

Authors:  Boubacar Efared; Asmae Mazti; Badarou Chaibou; Gabrielle Atsame-Ebang; Ibrahim Sory Sidibé; Layla Tahiri; Fatimazahra Erregad; Nawal Hammas; Abdelmajid El Mrini; Hinde El Fatemi; Laila Chbani
Journal:  BMC Clin Pathol       Date:  2017-04-07

3.  A Study on Clinical Characteristics and Magnetic Resonance Imaging Manifestations on Systemic Rosai-Dorfman Disease.

Authors:  Xiao Cheng; Jing-Liang Cheng; An-Kang Gao
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.